23 February 2026, Morges, Switzerland: Kainjoo confirms that its media arm, TreatMyBrand.com, is officially recognised as a member of the press. The accreditation has been issued by GNS Press, operator of presseausweis.com. TreatMyBrand.com’s published Editorial Mission and Guidelines define its operating standards: editorial independence, accuracy and verification, corrections, transparency, and a strict separation between editorial and commercial activity.

• TreatMyBrand.com recognised as press member by GNS Press (presseausweis.com)
• Haider Alleg appointed Editor-in-Chief, accountable for editorial standards, sourcing, and corrections
• Editorial mission: regulated industries and technology, with a cross-border Switzerland–EU–US lens

TreatMyBrand.com delivers field coverage through event reporting and on-the-record interviews with leaders in the space, including TechEx, Reuters Pharma, and Next Pharma. TreatMyBrand.com curates and syndicates news from relevant outlets worldwide, with clear attribution and cross-border context that supports decision-grade understanding. TreatMyBrand.com also serves as a growing press release and announcements platform, giving brands a disciplined channel to reach the market with news. A community inside TreatMyBrand.com supports discovery, dialogue, and distribution.

Regulated organisations face execution risk when product, data, and go-to-market systems cross jurisdictions. TreatMyBrand.com documents what changes, what transfers, and what breaks, connecting governance, technology, and real-world execution across Switzerland, the EU, and the US.